APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Retinoids

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral Retinoids Industry Research Report 2026

28 December 2025144 pages

Choose your research edition.

Industry ResearchOral Retinoids Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Retinoids Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oral Retinoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Retinoids Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Retinoids Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oral Retinoids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral Retinoids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral Retinoids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral Retinoids include Chongqing Huapont Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Shandong Liangfu Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, Harbin Dazhong Pharmaceutical, HEC Pharm, Zydus, Upsher-Smith and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral Retinoids market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Retinoids Market by Company

Chongqing Huapont Pharmaceutical

Sichuan Med-Shine Pharmaceutical

Shandong Liangfu Pharmaceutical

Heilongjiang Fuhe Pharmaceutical

Harbin Dazhong Pharmaceutical

HEC Pharm

Zydus

Upsher-Smith

Teva

Stiefel Laboratories

Sigmapharm Laboratories

Par Pharmaceutical

Mylan

Impax Laboratories

GlaxoSmithKline

Galderma Laboratories

Fuji Pharma

Dr. Reddy's Laboratories

Bausch Health

Barr Pharmaceuticals

Amneal Pharmaceuticals

Alembic

Actavis

Oral Retinoids Segment by Type

Alitretinoin

Acitretin

Bexarotene

Tretinoin

Isotretinoin

Oral Retinoids Segment by Application

Hospital and Clinic

Pharmacy

Other

Oral Retinoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Retinoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Retinoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Retinoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Retinoids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Retinoids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Retinoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Retinoids Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Retinoids Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Oral Retinoids Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Retinoids Revenue of Manufacturers (2021-2026) Table 9. Global Oral Retinoids Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Retinoids Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Oral Retinoids Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Retinoids, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Retinoids, Product Type & Application Table 14. Global Oral Retinoids Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Retinoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Huapont Pharmaceutical Company Information Table 19. Chongqing Huapont Pharmaceutical Business Overview Table 20. Chongqing Huapont Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio Table 22. Chongqing Huapont Pharmaceutical Recent Developments Table 23. Sichuan Med-Shine Pharmaceutical Company Information Table 24. Sichuan Med-Shine Pharmaceutical Business Overview Table 25. Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio Table 27. Sichuan Med-Shine Pharmaceutical Recent Developments Table 28. Shandong Liangfu Pharmaceutical Company Information Table 29. Shandong Liangfu Pharmaceutical Business Overview Table 30. Shandong Liangfu Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio Table 32. Shandong Liangfu Pharmaceutical Recent Developments Table 33. Heilongjiang Fuhe Pharmaceutical Company Information Table 34. Heilongjiang Fuhe Pharmaceutical Business Overview Table 35. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio Table 37. Heilongjiang Fuhe Pharmaceutical Recent Developments Table 38. Harbin Dazhong Pharmaceutical Company Information Table 39. Harbin Dazhong Pharmaceutical Business Overview Table 40. Harbin Dazhong Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio Table 42. Harbin Dazhong Pharmaceutical Recent Developments Table 43. HEC Pharm Company Information Table 44. HEC Pharm Business Overview Table 45. HEC Pharm Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. HEC Pharm Oral Retinoids Product Portfolio Table 47. HEC Pharm Recent Developments Table 48. Zydus Company Information Table 49. Zydus Business Overview Table 50. Zydus Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Zydus Oral Retinoids Product Portfolio Table 52. Zydus Recent Developments Table 53. Upsher-Smith Company Information Table 54. Upsher-Smith Business Overview Table 55. Upsher-Smith Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Upsher-Smith Oral Retinoids Product Portfolio Table 57. Upsher-Smith Recent Developments Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Teva Oral Retinoids Product Portfolio Table 62. Teva Recent Developments Table 63. Stiefel Laboratories Company Information Table 64. Stiefel Laboratories Business Overview Table 65. Stiefel Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Stiefel Laboratories Oral Retinoids Product Portfolio Table 67. Stiefel Laboratories Recent Developments Table 68. Sigmapharm Laboratories Company Information Table 69. Sigmapharm Laboratories Business Overview Table 70. Sigmapharm Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sigmapharm Laboratories Oral Retinoids Product Portfolio Table 72. Sigmapharm Laboratories Recent Developments Table 73. Par Pharmaceutical Company Information Table 74. Par Pharmaceutical Business Overview Table 75. Par Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Par Pharmaceutical Oral Retinoids Product Portfolio Table 77. Par Pharmaceutical Recent Developments Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Mylan Oral Retinoids Product Portfolio Table 82. Mylan Recent Developments Table 83. Impax Laboratories Company Information Table 84. Impax Laboratories Business Overview Table 85. Impax Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Impax Laboratories Oral Retinoids Product Portfolio Table 87. Impax Laboratories Recent Developments Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Oral Retinoids Product Portfolio Table 92. GlaxoSmithKline Recent Developments Table 93. Galderma Laboratories Company Information Table 94. Galderma Laboratories Business Overview Table 95. Galderma Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Galderma Laboratories Oral Retinoids Product Portfolio Table 97. Galderma Laboratories Recent Developments Table 98. Fuji Pharma Company Information Table 99. Fuji Pharma Business Overview Table 100. Fuji Pharma Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Fuji Pharma Oral Retinoids Product Portfolio Table 102. Fuji Pharma Recent Developments Table 103. Dr. Reddy's Laboratories Company Information Table 104. Dr. Reddy's Laboratories Business Overview Table 105. Dr. Reddy's Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Dr. Reddy's Laboratories Oral Retinoids Product Portfolio Table 107. Dr. Reddy's Laboratories Recent Developments Table 108. Bausch Health Company Information Table 109. Bausch Health Business Overview Table 110. Bausch Health Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bausch Health Oral Retinoids Product Portfolio Table 112. Bausch Health Recent Developments Table 113. Barr Pharmaceuticals Company Information Table 114. Barr Pharmaceuticals Business Overview Table 115. Barr Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Barr Pharmaceuticals Oral Retinoids Product Portfolio Table 117. Barr Pharmaceuticals Recent Developments Table 118. Amneal Pharmaceuticals Company Information Table 119. Amneal Pharmaceuticals Business Overview Table 120. Amneal Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Amneal Pharmaceuticals Oral Retinoids Product Portfolio Table 122. Amneal Pharmaceuticals Recent Developments Table 123. Alembic Company Information Table 124. Alembic Business Overview Table 125. Alembic Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Alembic Oral Retinoids Product Portfolio Table 127. Alembic Recent Developments Table 128. Actavis Company Information Table 129. Actavis Business Overview Table 130. Actavis Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Actavis Oral Retinoids Product Portfolio Table 132. Actavis Recent Developments Table 133. Global Oral Retinoids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Oral Retinoids Sales by Region (2021-2026) & (K Units) Table 135. Global Oral Retinoids Sales Market Share by Region (2021-2026) Table 136. Global Oral Retinoids Sales by Region (2027-2032) & (K Units) Table 137. Global Oral Retinoids Sales Market Share by Region (2027-2032) Table 138. Global Oral Retinoids Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Oral Retinoids Revenue Market Share by Region (2021-2026) Table 140. Global Oral Retinoids Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Oral Retinoids Revenue Market Share by Region (2027-2032) Table 142. North America Oral Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 144. North America Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 145. North America Oral Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Oral Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Oral Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 149. Europe Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 150. Europe Oral Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Oral Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Oral Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 154. Asia Pacific Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 155. Asia Pacific Oral Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Oral Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Oral Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 159. South America Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 160. South America Oral Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Oral Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Oral Retinoids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Oral Retinoids Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Oral Retinoids Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Oral Retinoids Sales by Type (2021-2026) & (K Units) Table 168. Global Oral Retinoids Sales by Type (2027-2032) & (K Units) Table 169. Global Oral Retinoids Sales Market Share by Type (2021-2026) Table 170. Global Oral Retinoids Sales Market Share by Type (2027-2032) Table 171. Global Oral Retinoids Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Oral Retinoids Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Oral Retinoids Revenue Market Share by Type (2021-2026) Table 174. Global Oral Retinoids Revenue Market Share by Type (2027-2032) Table 175. Global Oral Retinoids Price by Type (2021-2026) & (US$/Unit) Table 176. Global Oral Retinoids Price by Type (2027-2032) & (US$/Unit) Table 177. Global Oral Retinoids Sales by Application (2021-2026) & (K Units) Table 178. Global Oral Retinoids Sales by Application (2027-2032) & (K Units) Table 179. Global Oral Retinoids Sales Market Share by Application (2021-2026) Table 180. Global Oral Retinoids Sales Market Share by Application (2027-2032) Table 181. Global Oral Retinoids Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Oral Retinoids Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Oral Retinoids Revenue Market Share by Application (2021-2026) Table 184. Global Oral Retinoids Revenue Market Share by Application (2027-2032) Table 185. Global Oral Retinoids Price by Application (2021-2026) & (US$/Unit) Table 186. Global Oral Retinoids Price by Application (2027-2032) & (US$/Unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Oral Retinoids Distributors List Table 190. Oral Retinoids Customers List Table 191. Oral Retinoids Industry Trends Table 192. Oral Retinoids Industry Drivers Table 193. Oral Retinoids Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Retinoids Product Image Figure 5. Global Oral Retinoids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Retinoids Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Retinoids Sales (2021-2032) & (K Units) Figure 8. Global Oral Retinoids Average Price (US$/Unit) & (2021-2032) Figure 9. Alitretinoin Product Image Figure 10. Acitretin Product Image Figure 11. Bexarotene Product Image Figure 12. Tretinoin Product Image Figure 13. Isotretinoin Product Image Figure 14. Hospital and Clinic Product Image Figure 15. Pharmacy Product Image Figure 16. Other Product Image Figure 17. Global Oral Retinoids Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Oral Retinoids, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Oral Retinoids Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Oral Retinoids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Oral Retinoids Sales by Region in 2025 Figure 23. Global Oral Retinoids Revenue by Region in 2025 Figure 24. North America Oral Retinoids Market Size by Country in 2025 Figure 25. North America Oral Retinoids Sales Market Share by Country (2021-2032) Figure 26. North America Oral Retinoids Revenue Market Share by Country (2021-2032) Figure 27. United States Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Oral Retinoids Market Size by Country in 2025 Figure 31. Europe Oral Retinoids Sales Market Share by Country (2021-2032) Figure 32. Europe Oral Retinoids Revenue Market Share by Country (2021-2032) Figure 33. Germany Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Oral Retinoids Market Size by Country in 2025 Figure 44. Asia Pacific Oral Retinoids Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Oral Retinoids Revenue Market Share by Country (2021-2032) Figure 46. China Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Oral Retinoids Market Size by Country in 2025 Figure 55. South America Oral Retinoids Sales Market Share by Country (2021-2032) Figure 56. South America Oral Retinoids Revenue Market Share by Country (2021-2032) Figure 57. Brazil Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Oral Retinoids Market Size by Country in 2025 Figure 61. Middle East and Africa Oral Retinoids Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Oral Retinoids Revenue Market Share by Country (2021-2032) Figure 63. Egypt Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Oral Retinoids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Oral Retinoids Sales Market Share by Type (2021-2032) Figure 69. Global Oral Retinoids Revenue Market Share by Type (2021-2032) Figure 70. Global Oral Retinoids Price (US$/Unit) by Type (2021-2032) Figure 71. Global Oral Retinoids Sales Market Share by Application (2021-2032) Figure 72. Global Oral Retinoids Revenue Market Share by Application (2021-2032) Figure 73. Global Oral Retinoids Price (US$/Unit) by Application (2021-2032) Figure 74. Oral Retinoids Value Chain Figure 75. Oral Retinoids Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Oral Retinoids Industry Opportunities and Challenges

Scope & coverage.

Types
  • Alitretinoin
  • Acitretin
  • Bexarotene
  • Tretinoin
  • Isotretinoin
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Shandong Liangfu Pharmaceutical
  • Heilongjiang Fuhe Pharmaceutical
  • Harbin Dazhong Pharmaceutical
  • HEC Pharm
  • Zydus
  • Upsher-Smith
  • Teva
  • Stiefel Laboratories
  • Sigmapharm Laboratories
  • Par Pharmaceutical
  • Mylan
  • Impax Laboratories
  • GlaxoSmithKline
  • Galderma Laboratories
  • Fuji Pharma
  • Dr. Reddy's Laboratories
  • Bausch Health
  • Barr Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alembic
  • Actavis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Retinoids Market Size (2021-2032)
  4. 2.2.2 Global Oral Retinoids Sales (2021-2032)
  5. 2.2.3 Global Oral Retinoids Market Average Price (2021-2032)
  6. 2.3 Oral Retinoids by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Alitretinoin
  9. 2.3.3 Acitretin
  10. 2.3.4 Bexarotene
  11. 2.3.5 Tretinoin
  12. 2.3.6 Isotretinoin
  13. 2.4 Oral Retinoids by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital and Clinic
  16. 2.4.3 Pharmacy
  17. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Retinoids Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Retinoids Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Retinoids Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Retinoids Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Retinoids Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Retinoids, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Retinoids, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Retinoids, Established Date
  9. 3.9 Global Oral Retinoids Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Huapont Pharmaceutical
  2. 4.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 4.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 4.1.3 Chongqing Huapont Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio
  6. 4.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 4.2 Sichuan Med-Shine Pharmaceutical
  8. 4.2.1 Sichuan Med-Shine Pharmaceutical Company Information
  9. 4.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
  10. 4.2.3 Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio
  12. 4.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  13. 4.3 Shandong Liangfu Pharmaceutical
  14. 4.3.1 Shandong Liangfu Pharmaceutical Company Information
  15. 4.3.2 Shandong Liangfu Pharmaceutical Business Overview
  16. 4.3.3 Shandong Liangfu Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio
  18. 4.3.5 Shandong Liangfu Pharmaceutical Recent Developments
  19. 4.4 Heilongjiang Fuhe Pharmaceutical
  20. 4.4.1 Heilongjiang Fuhe Pharmaceutical Company Information
  21. 4.4.2 Heilongjiang Fuhe Pharmaceutical Business Overview
  22. 4.4.3 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio
  24. 4.4.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
  25. 4.5 Harbin Dazhong Pharmaceutical
  26. 4.5.1 Harbin Dazhong Pharmaceutical Company Information
  27. 4.5.2 Harbin Dazhong Pharmaceutical Business Overview
  28. 4.5.3 Harbin Dazhong Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio
  30. 4.5.5 Harbin Dazhong Pharmaceutical Recent Developments
  31. 4.6 HEC Pharm
  32. 4.6.1 HEC Pharm Company Information
  33. 4.6.2 HEC Pharm Business Overview
  34. 4.6.3 HEC Pharm Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 HEC Pharm Oral Retinoids Product Portfolio
  36. 4.6.5 HEC Pharm Recent Developments
  37. 4.7 Zydus
  38. 4.7.1 Zydus Company Information
  39. 4.7.2 Zydus Business Overview
  40. 4.7.3 Zydus Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Zydus Oral Retinoids Product Portfolio
  42. 4.7.5 Zydus Recent Developments
  43. 4.8 Upsher-Smith
  44. 4.8.1 Upsher-Smith Company Information
  45. 4.8.2 Upsher-Smith Business Overview
  46. 4.8.3 Upsher-Smith Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Upsher-Smith Oral Retinoids Product Portfolio
  48. 4.8.5 Upsher-Smith Recent Developments
  49. 4.9 Teva
  50. 4.9.1 Teva Company Information
  51. 4.9.2 Teva Business Overview
  52. 4.9.3 Teva Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Teva Oral Retinoids Product Portfolio
  54. 4.9.5 Teva Recent Developments
  55. 4.10 Stiefel Laboratories
  56. 4.10.1 Stiefel Laboratories Company Information
  57. 4.10.2 Stiefel Laboratories Business Overview
  58. 4.10.3 Stiefel Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Stiefel Laboratories Oral Retinoids Product Portfolio
  60. 4.10.5 Stiefel Laboratories Recent Developments
  61. 4.11 Sigmapharm Laboratories
  62. 4.11.1 Sigmapharm Laboratories Company Information
  63. 4.11.2 Sigmapharm Laboratories Business Overview
  64. 4.11.3 Sigmapharm Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sigmapharm Laboratories Oral Retinoids Product Portfolio
  66. 4.11.5 Sigmapharm Laboratories Recent Developments
  67. 4.12 Par Pharmaceutical
  68. 4.12.1 Par Pharmaceutical Company Information
  69. 4.12.2 Par Pharmaceutical Business Overview
  70. 4.12.3 Par Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Par Pharmaceutical Oral Retinoids Product Portfolio
  72. 4.12.5 Par Pharmaceutical Recent Developments
  73. 4.13 Mylan
  74. 4.13.1 Mylan Company Information
  75. 4.13.2 Mylan Business Overview
  76. 4.13.3 Mylan Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Mylan Oral Retinoids Product Portfolio
  78. 4.13.5 Mylan Recent Developments
  79. 4.14 Impax Laboratories
  80. 4.14.1 Impax Laboratories Company Information
  81. 4.14.2 Impax Laboratories Business Overview
  82. 4.14.3 Impax Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Impax Laboratories Oral Retinoids Product Portfolio
  84. 4.14.5 Impax Laboratories Recent Developments
  85. 4.15 GlaxoSmithKline
  86. 4.15.1 GlaxoSmithKline Company Information
  87. 4.15.2 GlaxoSmithKline Business Overview
  88. 4.15.3 GlaxoSmithKline Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 GlaxoSmithKline Oral Retinoids Product Portfolio
  90. 4.15.5 GlaxoSmithKline Recent Developments
  91. 4.16 Galderma Laboratories
  92. 4.16.1 Galderma Laboratories Company Information
  93. 4.16.2 Galderma Laboratories Business Overview
  94. 4.16.3 Galderma Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Galderma Laboratories Oral Retinoids Product Portfolio
  96. 4.16.5 Galderma Laboratories Recent Developments
  97. 4.17 Fuji Pharma
  98. 4.17.1 Fuji Pharma Company Information
  99. 4.17.2 Fuji Pharma Business Overview
  100. 4.17.3 Fuji Pharma Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Fuji Pharma Oral Retinoids Product Portfolio
  102. 4.17.5 Fuji Pharma Recent Developments
  103. 4.18 Dr. Reddy's Laboratories
  104. 4.18.1 Dr. Reddy's Laboratories Company Information
  105. 4.18.2 Dr. Reddy's Laboratories Business Overview
  106. 4.18.3 Dr. Reddy's Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Dr. Reddy's Laboratories Oral Retinoids Product Portfolio
  108. 4.18.5 Dr. Reddy's Laboratories Recent Developments
  109. 4.19 Bausch Health
  110. 4.19.1 Bausch Health Company Information
  111. 4.19.2 Bausch Health Business Overview
  112. 4.19.3 Bausch Health Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Bausch Health Oral Retinoids Product Portfolio
  114. 4.19.5 Bausch Health Recent Developments
  115. 4.20 Barr Pharmaceuticals
  116. 4.20.1 Barr Pharmaceuticals Company Information
  117. 4.20.2 Barr Pharmaceuticals Business Overview
  118. 4.20.3 Barr Pharmaceuticals Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Barr Pharmaceuticals Oral Retinoids Product Portfolio
  120. 4.20.5 Barr Pharmaceuticals Recent Developments
  121. 4.21 Amneal Pharmaceuticals
  122. 4.21.1 Amneal Pharmaceuticals Company Information
  123. 4.21.2 Amneal Pharmaceuticals Business Overview
  124. 4.21.3 Amneal Pharmaceuticals Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Amneal Pharmaceuticals Oral Retinoids Product Portfolio
  126. 4.21.5 Amneal Pharmaceuticals Recent Developments
  127. 4.22 Alembic
  128. 4.22.1 Alembic Company Information
  129. 4.22.2 Alembic Business Overview
  130. 4.22.3 Alembic Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Alembic Oral Retinoids Product Portfolio
  132. 4.22.5 Alembic Recent Developments
  133. 4.23 Actavis
  134. 4.23.1 Actavis Company Information
  135. 4.23.2 Actavis Business Overview
  136. 4.23.3 Actavis Oral Retinoids Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Actavis Oral Retinoids Product Portfolio
  138. 4.23.5 Actavis Recent Developments
5 Global Oral Retinoids Market Scenario by Region
  1. 5.1 Global Oral Retinoids Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Retinoids Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Retinoids Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Retinoids Sales by Region: 2027-2032
  5. 5.3 Global Oral Retinoids Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Retinoids Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Retinoids Revenue by Region: 2027-2032
  8. 5.4 North America Oral Retinoids Market Facts & Figures by Country
  9. 5.4.1 North America Oral Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Retinoids Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Retinoids Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral Retinoids Market Facts & Figures by Country
  16. 5.5.1 Europe Oral Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral Retinoids Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral Retinoids Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral Retinoids Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral Retinoids Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral Retinoids Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral Retinoids Market Facts & Figures by Country
  41. 5.7.1 South America Oral Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral Retinoids Sales by Country (2021-2032)
  43. 5.7.3 South America Oral Retinoids Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Oral Retinoids Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Oral Retinoids Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Oral Retinoids Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Oral Retinoids Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral Retinoids Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Retinoids Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Oral Retinoids Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Retinoids Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Retinoids Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Retinoids Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Retinoids Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Retinoids Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Retinoids Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Oral Retinoids Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Retinoids Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Retinoids Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Retinoids Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Retinoids Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Retinoids Value Chain Analysis
  2. 8.1.1 Oral Retinoids Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Retinoids Production Mode & Process
  5. 8.2 Oral Retinoids Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Retinoids Distributors
  8. 8.2.3 Oral Retinoids Customers
9 Global Oral Retinoids Analyzing Market Dynamics
  1. 9.1 Oral Retinoids Industry Trends
  2. 9.2 Oral Retinoids Industry Drivers
  3. 9.3 Oral Retinoids Industry Opportunities and Challenges
  4. 9.4 Oral Retinoids Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst